Abstracts

💡 The latest in respiratory research and best practice / service development to inspire your work.

Listed below are all the accepted abstracts from the PCRS Respiratory Conference 2026.

93 results

Using a modified Esther model to develop a blueprint for Neighbourhood Health in chronic obstructive pulmonary disease (COPD) (ID 797)

Katherine Hickman, on behalf of PCRS committees and neighbourhood health project group

Primary Care Respiratory Society (PCRS)

MDI Optimisation Service: A Neighbourhood Health Initiative Removing the Adherence Blind Spot through GP-Pharmacy Cooperation (ID 801)

Negandhi D, Antalffy T

Smart Respiratory

Modifiable Risk Factors in patients referred to Severe Asthma Services: Implications for Primary Care Education and Referral

Could medicine optimisation and improved patient adherence in primary care reduce the number of patients referred to the secondary care difficult asthma service? (ID 802)

Greenwood S, O’Driscoll M, Beswick S, Haughney J, McKnight E

National Services for Health Improvement

Are Patients with Cluster Headache Prescribed Short-Burst Oxygen Adequately Assessed and Monitored? (ID 804)

Imogah SE, Wilson V, Thomas R

Whaddon Medical Centre

Improving inpatient screening for Undiagnosed Obstructive Sleep Apnoea in High-Risk Respiratory Admissions. (ID 805)

Ghafar R, Pornsakulpaisal R, Khan A,Pradhan A.

University hospitals Derby and Burton NHS trust

Operational performance of an artificial intelligence-enabled diagnostic service for chronic obstructive pulmonary disease in primary care (ID 806)

Greason C, Cook L, Harris D, Jordan M, Varghese A, Dempsey J

GP Primary Choice

Is ambulatory oxygen necessary and utilized on post hospital discharge (ID 807)

Wilson VL, Thomas R

Whaddon Medical Centre

Embedding meaningful patient and public involvement from application to dissemination: lessons from IMP2ART (ID 810)

Jackson T, Ehrlich E, Morgan N, Hammersley V, Healy E, Taylor SJC, Pinnock H

University of Edinburgh

Online Consultations for Asthma Care: Evidence and Practice (ID 811)

Uzzaman N, Hammersley V, Sheringham J, McClatchey K, Habib GMM, Singh D, Pinnock H

The University of Edinburgh

How engagement in pulmonary rehabilitation is affected by the addition of a social prescribing link worker to the multi-disciplinary team. (ID 813)

Parker N, Pritchard L, Moth L

Guys and St Thomas Trust

Reducing health inequalities in pulmonary rehabilitation with social prescribing. (ID 814)

Parker N, Pritchard L, Moth L

Guys and St Thomas Trust

Moderate and Severe COPD Exacerbations Lead to Sustained Impairment in Health-related Quality of Life (ID 815)

Yang S, Weir J, Dalén J, Hughes O, Martin A, Baker T, Shah D, Gould S

GSK

Disease Stability is Achievable in a Wide Spectrum of Patients with Chronic Obstructive Pulmonary Disease Receiving Mepolizumab: Pooled Results From Phase III Randomized Controlled Trials (ID 816)

Singh D, Vogelmeier CF, Martinez FJ, Roche N, Watz H, Bolaji J, Biswas A, Stacey R, Kolterer, Han MK

GSK

Transforming COPD Care across the Humber: proactive identification and risk management across the care pathway (Humber COPD ProCare) (ID 818)

Crooks MG, Watkins K, Brindle K, Blackwell K, Denham I, Drydale O, Bowness D, Deayton N, Faruqi S.

NHS Humber Health Partnership

Raised Blood Eosinophil Counts are Associated with High Airway Type 2 Inflammation in Chronic Obstructive Pulmonary Disease (ID 820)

Chari S, Weir J, Betts J, Min J, Kolterer S, Chen R

GSK

Evidence-based implementation for large scale change in asthma management - a collation of case studies submitted to NICE on implementation of guideline NG245 - Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) (ID 822)

McCormack J, Taylor E

National Institute for Health and Care Excellence

Warm Homes, Better Breathing: A Neighbourhood Approach to Supporting Respiratory Patients Affected by Fuel Poverty (ID 824)

Clarke R, Green D, Tinnion P, Southern S, Astbury A

The Innovation Agency (Academic Health Science Network for the North West Coast)

Improving COPD Rescue Pack Management in a Deprived Primary Care Network: A Pharmacy Technician-Led Pilot (ID 825)

Kadar D, Burns S, Ahmed A, Tariq B, Keane L, Dr Razvi A.

Liverpool First Primary Care Network

A Breath of Fresh AIR: A Two-Cycle Primary Care Service Improvement Project to Reduce SABA Monotherapy (ID 827)

Hamilton H, Dewar J, Cooper S

Pioneer Medical Group

Improving COPD Outcomes in Primary Care Through Holistic Reviews, Inhaler Optimisation and Multimorbidity Management (ID 828)

Hardaker L

Priory Medical Group, Haxby Group Practice, Selby Town PCN and York Medical Group in York, North Yorkshire

Integrated COPD Optimisation in Primary Care: Improving Outcomes Through Inhaler Technique and Multimorbidity Management (ID 829)

Latife Hardaker¹
¹Priory Medical Group /Haxby Group Practice/Selby Town PCN,York Medical Group

Priory Medical Group, Haxby Group Practice, Selby Town PCN and York Medical Group in York, North Yorkshire

A service improvement project to harness the benefits of ICS/Formoterol reliever therapy for patients attending the Emergency Department for acute exacerbations of asthma (ID 830)

Wiffen L, De Vos R, Lizarondo M, Herbert S, Brown TP

Portsmouth Hospitals University NHS Trust

Identifying unmet COPD need by delivering pharmacist-led risk stratification and optimisation at scale in primary care in 2025. (ID 835)

Kang A

Screen Clinical

Offering home sensors to families of children with high-risk respiratory conditions: a feasibility study to connect NHS and housing pathways (ID 836)

Adegboye O, Ali S, Littleford K, Sheringham J

University College London (UCL)

Optimising opportunities for capacity building within programme grants: the example of the IMP2ART programme (ID 837)

Pinnock H, Hammersley V, Delaney B, Kinley E, Korell B, McClatchey K, Uzzaman N, Sheringham J, Steed L, MacLeod C, Taylor S on behalf of the IMP2ART investigators.

The University of Edinburgh

Conference Sponsors

Thank you to this year's conference sponsors

AstraZeneca UK Limited
Chiesi Limited

The conference has been instigated and organised by PCRS. We are grateful to our sponsors and exhibitors, including pharmaceutical companies, who have contributed funding towards the event in return for exhibition space, sponsored symposia and/or other marketing opportunities. Neither sponsors nor exhibitors have had any input into the agenda or the selection of speakers with the exception of sponsored satellite symposia which are clearly indicated. The conference social programme - dinner and drinks - is not covered by sponsorship or exhibition fees. View the full list of conference exhibitors and corporate sponsors.